Table 4.
Taxon | Family | Species | Chemical Class | Substance | Target Species | Development Stage | Magnitude of Activity | Model | Against | Ref. | |
---|---|---|---|---|---|---|---|---|---|---|---|
IC50 (μg/mL) | MIC (g/mL) | ||||||||||
Anurans | Bufonidae | Rhinella marina | Bufadienolide | Telocinobufagin | P. f. | Trophozoites | 1.28 | ND | In vitro | CQ-resistant strain | [95] |
Bufonidae | Rhaebo guttatus | Bufadienolide | Telocinobufagin | P. f. | Trophozoites | 1.28 | ND | In vitro | CQ-resistant strain | [95] | |
Bufonidae | Rhinella marina | Alkaloid | Dehydrobufotenine | P. f. | Trophozoites | 19.11 | ND | In vitro | CQ-resistant strain | [122] | |
Bufonidae | Rhinella marina | Bufadienolide | Marinobufotoxin | P. f. | Trophozoites | 5.31 | ND | In vitro | CQ-resistant strain | [122] | |
Bufonidae | Rhinella marina | Bufadienolide | Marinobufagin | P. f. | Trophozoites | 3.89 | ND | In vitro | CQ-resistant strain | [122] | |
Bufonidae | Rhinella marina | Bufadienolide | Bufalin | P. f. | Trophozoites | 3.44 | ND | In vitro | CQ-resistant strain | [122] | |
Bufonidae | Not specified | Crude extract | Crude extract | P. berghei | ND | ND | ND | In vivo | Parasitemia | [98] | |
Hylidae | Phyllomedusa azurea | Peptide | Phylloseptin-1 | P. f. | Trophozoites | ND | 128 | In vivo | Parasite growth in erythrocytes | [128] | |
Leptodactylidae | Leptodactylus labyrinthicus | Peptide | Oc-P1 (ocellatins) | P. f. | Trophozoites | 26.71 | ND | In vitro | CQ-resistant strain | [155] | |
Pipidae | Xenopus laevis | Peptide | Magainin2 | An. Gambiae | Zygotes, ookinetes, and merozoites | ND | 0.5–1 | In vitro | Parasite development in the mosquito | [156] | |
Bufonidae | Rhinella marina | Crude extract | Crude extract | P. f. | Trophozoites | 2.43 | ND | In vitro | CQ-resistant strain | [120] | |
Spiders | Theraphosidae | Psalmopoeus cambridgei | Peptide | Psalmopeotoxin I (PcFK1) | P. f. | Intraerythrocytic cycle | 116 | ND | In vitro | Artemisinin-resistant strain | [157] |
Theraphosidae | Psalmopoeus cambridgei | Peptide | Psalmopeotoxin I (PcFK1) | P. f. | Trophozoites | 1.59 | ND | In vitro | Parasite growth in erythrocytes | [136] | |
Theraphosidae | Psalmopoeus cambridgei | Peptide | Psalmopeotoxin II (PcFK2) | P. f. | Trophozoites | 1.15 | ND | In vitro | Parasite growth in erythrocytes | [136] | |
Theraphosidae | Psalmopoeus cambridgei | Peptide | Psalmopeotoxin II’ (PcFK2’) | P. f. | Trophozoites | 9.2 | ND | In vitro | Parasite growth in erythrocytes | [158] | |
Theraphosidae | Acanthoscurria gomesiana | Peptide | Gomesin | P. f. | Intraerythrocytic cycle | 75.8–86.6 | ND | In vitro | Parasite growth in erythrocytes | [159] | |
Scorpions | Scorpionidae | Pandinus imperator | Peptide | Scorpine | P. berghei | Ookinetes and gametes | ND | 50 μM (fertilization); 3 μM (ookinete) | In vitro | Development of the para-site | [97] |
Buthidae | Mesobuthus eupeus | Peptide | Meucin-24 | P. f./P. berghei | Inhibi-ting the erythrocyte development | ND | 40%;10 a 20 μM (inhibiting the development) | In vitro | Parasite growth in erythrocytes | [139] | |
Buthidae | Mesobuthus eupeus | Peptide | Meucin-25 | P. f./P. berghei | Inhibiting the erythrocyte development | ND | 50%;10 a 20 μM (inhibiting the development) | In vitro | Parasite growth in erythrocytes | [139] | |
Vaejovidae | Vaejovis mexicanus | Peptide | VmCT1-NH2 | P. gallinaceum | Sporozoites | 0.49 | ND | In vitro | Dead-cell staining | [140] | |
Vaejovidae | Vaejovis mexicanus | Peptide | [Arg]3-VmCT1-NH2 | P. gallinaceum | Sporozoites | 0.57 | ND | In vitro | Dead-cell staining | [140] | |
Vaejovidae | Vaejovis mexicanus | Peptide | [Arg]7-VmCT1-NH2 | P. gallinaceum | Sporozoites | 0.51 | ND | In vitro | Dead-cell staining | [140] | |
Vaejovidae |
Vaejovis mexicanus
|
Peptide | [Arg]11-VmCT1-NH2 |
P. gallinaceum | Sporozoites | >1.6 | ND | In vitro | Dead-cell staining | [140] | |
Snakes | Viperidae | Bothrops asper | Crude extract | Crude extract | P. f. | Intra-erythrocytic cycle | 0.13 | ND | In vitro | CQ-resistant strain | [96] |
Viperidae | Bothrops asper | Enzyme | Fração V (Phospholipase A2) | P. f. | Intra-erythrocytic cycle | 1.42 | ND | In vitro | CQ-resistant strain | [96] | |
Viperidae | Bothrops asper | Homologous | Fração VI (Homologo Phospholipase A2) | P. f. | Intra-erythrocytic cycle | 323.35 | ND | In vitro | CQ-resistant strain | [96] | |
Elapidae | Bungarus fasciatus | Peptide | LZ1 | P. f. | Intra-erythrocytic cycle | 3.045 | ND | In vitro | CQ-resistant strain | [107] | |
Elapidae | Bungarus fasciatus | Peptide | LZ1 | P. berghei | Intra-erythrocytic cycle | ND | 39% (4 mg/kg), 35% (8 mg/kg) e 24% (12 mg/kg) | In vivo | CQ-resistant strain | [107] | |
Viperidae | Bothrops marajoensis | Enzyme | BmajPLA2-II | P. f. | Intra-erythrocytic cycle | 6.41 | ND | In vitro | CQ-resistant strain | [112] | |
Viperidae | Agkistrodon halys | Enzyme | Phospholipase A2 (IIA) | P. f. | Intraerythrocytic development | 82.3 | ND | In vitro | Parasite growth in erythrocytes | [110] | |
Elapidae | Naja mossambica mossambica | Enzyme | Phospholipase A2 (IA) | P. f. | Intraerythrocytic development | 0.023 | ND | In vitro | Parasite growth in erythrocytes | [110] | |
Elapidae | Naja scutatus scutatus | Enzyme | Phospholipase A2 (IA) | P. f. | Intraerythrocytic development | 2.6 | ND | In vitro | Parasite growth in erythrocytes | [110] | |
Viperidae | Vipera ammodytes | Enzyme | Phospholipase A2 (IIA) | P. f. | intraerythrocytic development | 2.8 | ND | In vitro | Parasite growth in erythrocytes | [110] | |
Elapidae | Naja naja oxiana | Extract | Fraction 4 | P. f. | Intraerythrocytic development | 0.368 | ND | In vitro | Parasite growth in erythrocytes | [104] | |
Elapidae | Naja naja oxiana | Extract | Fraction 4 | P. berghei | Intraerythrocytic development | ND | 70%(5 mg/kg); 50%(2.5 mg/kg); 30%(1 mg/kg) | In vivo | Parasite growth in erythrocytes | [105] | |
Viperidae | Bothrops brazili | Metalloproteinase | BbMP-1 | P. f. | Intra-erythrocytic development | 3.2 | ND | In vitro | Parasite growth in erythrocytes | [160] | |
Viperidae | Crotalus durissus | Peptide | Crotamine | P. f. | Intra-erythrocytic development | 1.87 | ND | In vitro | CQ-resistant strain | [106] | |
Viperidae | Crotalus durissus cumanensis | Enzyma (Fraction 1) | Crotoxin (Phospholipase A2) | P. f. | Intra-erythrocytic development | 0.17 | ND | In vitro | CQ-resistant strain | [111] | |
Viperidae | Crotalus durissus cumanensis | Enzyme (Fraction 2) | Crotoxin (Phospholipase A2) | P. f. | Intra-erythrocytic development | 0.76 | ND | In vitro | CQ-resistant strain | [111] | |
Viperidae | Crotalus durissus cumanensis | Enzyme | Crotoxin B (Phospolipase A2) | P. f. | Intra-erythrocytic development | 0.6 | ND | In vitro | CQ-resistant strain | [111] | |
Viperidae | Crotalus durissus cumanensis | Crude extract | Crude extract | P. f. | Intra-erythrocytic development | 0.17 | ND | In vitro | CQ-resistant strain | [111] | |
Viperidae | Bothrops asper | Enzyme | BaspAc-II | P. f. | Intra-erythrocytic development | 2.46 | ND | In vitro | CQ-resistant strain | [114] | |
Viperidae | Bothrops asper | Enzyme | BaspAc-IV | P. f. | Intra-erythrocytic development | 0.019 | ND | In vitro | CQ-resistant strain | [114] | |
Elapidae | Micrurus spixii | Crude extract | Crude extract | P. f. | Intra-erythrocytic development | ≤0.78 | ND | In vitro | CQ-resistant strain | [103] | |
Viperidae | Bothrops diporus | Enzyme | BdTX-I (Phospholipase A2) | P. f. | Intra-erythrocytic development | 2.44 | ND | In vitro | CQ-resistant strain | [113] | |
Viperidae | Bothrops diporus | Enzyme | BdTX-II (Phospholipase A2) | P. f. | Intra-erythrocytic development | 0.0153 | ND | In vitro | CQ-resistant strain | [113] | |
Viperidae | Bothrops diporus | Enzyme | BdTX-III (Phospholipase A2) Homologo | P. f. | Intra-erythrocytic development | 0.59 | ND | In vitro | CQ-resistant strain | [113] | |
Viperidae | Crotalus adamanteus | Enzyme | Phospholipase A2 | P. gallinaceum | Oocyst formation | ND | ND | In vitro | ND | [109] | |
Bees | Not applicable | Not applicable | Enzyme | Phospholipase A2 | P. f. | Young trophozoites | 1.1 × 10−6 | ND | In vitro | Intra-erythrocytic growth | [154] |
Not applicable | Not applicable | Enzyme | Phospholipase A3 | P. f. | Tropho-zoites | 1.69 × 10−5 | ND | In vitro | Intraerythrocytic growth | [110] | |
Not applicable | Not applicable | Enzyme | Phospholipase A2 | P. f. | Mature trophozoites | ND | ND | In vitro | Intraerythrocytic growth | [155] | |
Apidae | Apis mellifera | Enzyme | Phospholipase A3 | P. berghei | Oocysts | ND | ND | In vitro | Development of the parasite | [149] | |
Not applicable | Not described | Enzyme | Phospholipase A3 | P. gallinaceum | Oocysts | ND | ND | In vitro | Development of the parasite | [150] | |
Apidae | Apis mellifera | Peptide | Melittin | P. f. | Not specified | 10 | ND | In vitro | Intraerythrocytic growth | [143] | |
Not applicable | Not applicable | Enzyme | Phospholipase A3 | P. f. | Not specified | ND | ND | In vitro | Intraerythrocytic growth | [151] | |
Not applicable | Not applicable | Enzyme | Phospholipase A3 | P. f. | Schizonts | ND | ND | In vitro | Parasitemia | [148] | |
Not applicable | Not applicable | Enzyme | Phospholipase A4 | P. f. | Trophozoites and schizonts | ND | ND | In vitro | Parasitemia | [153] | |
Not applicable | Not applicable | Peptide | Melittin | P. f. | Trophozoites and schizonts | ND | ND | In vitro | Development of the parasite | [94] | |
Not applicable | Not applicable | Peptide | Melittin | P. f. | Trophozoites | ND | ND | In vitro and in vivo | Parasitemia | [144] | |
Not applicable | Not applicable | Enzyme | Phospholipase A5 | P. knowlesi | Trophozoites | ND | ND | In vitro | Intraerythrocytic growth | [147] |
Abbreviations: IC50—Half-maximal inhibitory concentration; MIC—Minimum inhibitory concentration; Not determined (ND); NMR 1H—Hydrogen-1 nuclear magnetic resonance; NMR 13C—Carbon-13 nuclear magnetic resonance; F-moc—Fluorenylmethoxycarbonyl protecting group; HPLC—High-performance liquid chromatography; MALDI-TOF—Matrix-assisted laser desorption/ionization-time of flight; TOF MS—Time-of-flight mass spectrometry; RP-HPLC—Reversed-phase HPLC; SDS-PAGE—Sodium dodecyl sulfate-polyacrylamide gel electrophoresis; Ref.—References; P. f.—Plasmodium falciparum; P. v.—Plasmodium vivax; CQ—chloroquine.